4//SEC Filing
GUTHART LEO 4
Accession 0001104659-20-121613
CIK 0001796280other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 8:56 AM ET
Size
11.4 KB
Accession
0001104659-20-121613
Insider Transaction Report
Form 4
Topspin Biotech Fund II, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-11-04−2,268,750→ 1,100,446 total(indirect: See Footnote)
LG Management, LLC
10% Owner
Transactions
- Sale
Common Stock
2020-11-04−2,268,750→ 1,100,446 total(indirect: See Footnote)
GUTHART LEO
10% Owner
Transactions
- Sale
Common Stock
2020-11-04−2,268,750→ 1,100,446 total(indirect: See Footnote)
Topspin Fund L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-11-04−2,268,750→ 1,100,446 total(indirect: See Footnote)
Footnotes (3)
- [F1]Consists of (1) 1,043,874 shares held of record by Topspin Fund, LP.; and (2) 56,572 shares owned by Leo A Guthart, individually. Each of Topspin Fund, LP and Leo A. Guthart disclaims beneficial ownership of the shares held of recod by the other.
- [F2]On November 4, 2020, Topspin Biotech Fund II, L.P. distributed the 2,268,750 shares owned by it as follows: (1) 2,155,607 shares were distributed in-kind to its limited partners; and (2) 113,143 were distributed at the direction of LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., as follows: (a) 56,572 were distributed to Leo A. Guthart, the managing member of LG Management, LLC; and (b) an aggregate of 56,571 were distributed to two third-parties. The 113,143 shares distributed at the direction of LG Management, LLC were shares to which it was entitled in its capacity as general partner of Topspin Biotech Fund II, L.P.
- [F3]1,043,874 of such shares are held directly by Topspin Fund L.P. LG Management, LLC, the general partner of Topspin Fund L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.
Documents
Issuer
Oric Pharmaceuticals, Inc.
CIK 0001796280
Entity typeother
Related Parties
1- filerCIK 0001200183
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 8:56 AM ET
- Size
- 11.4 KB